A B S T R A C T We studied 25 duodenal ulcer patients and 14 age-and sex-matched normal controls to determine whether gastric acid secretion in duodenal ulcer patients is abnormally sensitive to stimulation by gastrin endogenously released in response to meals. Acid response to saline and to 0.5, 1.0, 2.0, 4.0, and 8.0% peptone infused into the stomach was measured by 30 min intragastric titration. Total serum gastrin (G-total) and serum heptadecapeptide gastrin (G17), fasting and 30 min after each test meal, were measured by specific radioimmunoassays. In 19 ulcer patients and 11 normal subjects (controls), acid response to graded doses (11, 33, 100, and 300 pmol kg-I h-1) of G17-I were also measured.
ulcer patients than in controls both in the overall group and in pairs of ulcer patients and controls matched on the basis of highest observed mealstimulated acid responses, or on the basis of maximal acid output in response to synthetic human G17. The dose of exogenously administered G17 required for half maximal G17 acid response mean D50G, was significantly less in patients than in control subjects. In both ulcer and control subjects, D50G correlated significantly with D50M. This and the significant correlation between meal-stimulated G17 and acid response strongly suggest that the endogenously released gastrin was responsible for most, if not all, of the postpeptone acid output.
We conclude that after peptone test meals, gastric acid secretion in duodenal ulcer patients was ab-
INTRODUCTION
Studies with graded doses of pentagastrin (1) and heptadecapeptide gastrin (G 17)1 (2) given by intravenous infusion to duodenal ulcer patients and normal subjects showed that the dose of gastrin required to produce half maximal gastric acid secretory response (D50) was significantly lower in duodenal ulcer patients than in normal subjects. This indicates that duodenal ulcer patients as a group are more sensitive than normal to stimulation by exogenous gastrins. The purpose of this study was to determine whether gastric acid secretion in duodenal ulcer patients is abnormally 'Abbreviations used in this paper: D50G, dose of gastrin required to produce half maximal gastric acid secretory response; DsoM, gastrin concentration corresponding to half maximal meal-stimulated acid response; G17, heptadecapeptide gastrin; G-total, total serum gastrin.
sensitive to stimulation by gastrin endogenouxsly released in response to proteini meeals.
Once the menasurement of postprandial acid secretion in huma-n subjects became possible by the method of intragastric titration (3) , attempts were made to correlate acid secretion with postprandial serumn gastrin concentrattioins, but no correlations were founld (3, 4) . This, however, is not unexpected, as these stuidies were based on the acid and gastrin responses to a single level of stimulation by a standard meal in different individuals. Because it is likely that given serum concentratioins of endogenous gastrin wvill not produce similar rates of acid output in all sul)jects, a correlation lbetweeni acid secretion and gastrin releasie might not be found between individuals even if suich a correlation were present within individualls. In accordance with this, a significaint correlation (r = 0.97) between gastric acid secretion andl serumii gastrini was observed when responses to various intragastric stimuli of different potencies were measutred in at grouip of normal siubljects (4) . This suiggests that if one gives graded doses of a single intragastric stimullus, a correlation letween acid anid gastrin responses can be expected wTithin individuals.
Feldmian et tl. (5) measuired acid secretion and sertum G17 concentrations (ulsinlg a specific radioimmunoassay) in response to an intragastric amiino acid meal and to graded doses of G17 given by intravenouis inftusion. They found that the rise in plasma G17 concentration in response to the intragastric aimino acids couild have produced all of the observed acid secretion, stuggesting that G17 is the maijor physiologic stimulant in response to at meal. We therefore compared the sensitivity of dtlodenal uilcer pattients and normal subjects to endogenouis gastrin by sttudying the responses of gastric acid secretion annd seruim gastrin, incltuding G17, with increasing doses of' intr-agastric peptone. from each other, and that the cumulative acid output to all doses of peptone using these two intervals was also similar (20.8±4.2 and 18.8+4.0 mmol 105 min-', respectively). Fuirthermore, increasing the peptone dose to 10% did not cause a significant increase in acid output over the 8% dose (13.1±2.0 and 13.3+2.2 mmol 30 min-', respectively).
NMETHODS
Sinigle-day vs. multiple-day tests. In two subjects, one duodenal ulcer patient and one control, the acid secretory responises did not differ significantly whether the test meals were given sequentially on a single day or individually in random order on 6 separate d. The correlation coefficient of the pairs of results in the two subjects was 0.96 and the mean variation of individual results was 10.3%.
G17 maximal acid output. On a separate day, maximal acid output in response to intravenous infusion over 30 min by a syringe infusion pump (Harvard Apparatus Co., Inc., Millis, Mass.) of 300 pmol kg-' h-' G17 (synthetic human G17-I, Imperial Chemical Industries, Inc., Los Angeles, Calif.) was measured in 23 of the 25 duodenal ulcer patients and 13 of the 14 controls, using conventional methods (gastric aspiration and in vitro titration) (6). Earlier dose-response studies from this laboratory (2) showed that this dose of G17 produced maximal acid output both in normal subjects and in duodenal ulcer patients. Furthermore, dose-response studies in three normal subjects and three duodenal ulcer patients indicated that the maximal acid output achieved by 300 pmol kg-' h-' G17 and by 7.8 nmol (6 ,ug) kg-' h-' pentagastrin did not differ significantly.
G17 dose-response study. On another day, after collection of 30 min basal secretion as described above, acid output in response to intravenous infusion of 11, 33, 100, and 300 pmol kg-' h-l G17 (see above) was measured for 30 min after each dose in 19 of the 25 duodenal ulcer patients and 11 of the 14 controls. The doses of G17 were given sequentially in the order listed, and each dose was given for 30 min by a syringe infusion pump. The method and validation of the test have been previously described in detail (1, 2). It was established that the acid secretory responses did not differ significantly whether the doses of G17 were given sequentially on a single day or individually in random order on 4 separate d.
Gastrin estimation. During the peptone-meal study, blood for gastrin determination was drawn with an indwelling venous catheter before the first meal and 30 min after the instillation of each test meal, and was kept at 4°C. At the end of the test, the sera were immediately separated by centrifugation and stored at -20°C for subsequent radioimmunoassay.
Serum total carboxy-terminal immunoreactive gastrin (G-total). This was measured by radioimmunoassay. All samples were tested in duplicate. Antibody 1296, a rabbit antigastrin prepared by immunization with G17 conjugated to bovine serum albumin, was used at a final dilution of 1:300,000 (7) . With this antiserum, human G17 and human big gastrin were measured on a nearly equimolar basis. Crossreactivity with porcine cholecystokinin was <5% (8).
Serum immunoreactive G17. Serum G17 concentration was measured using L6, an antibody that has almost absolute s1)ecificity for G17 I and II. The characteristics of this antibody have been recently described in detail (9) . Samples were run in duplicate at 1:10 dilution and read against a standard culrve of G17 diluted in 10% gastrin-free serum prepared by charcoal extraction.
Statistical methods. Linear regression by least-squares and t tests, paired and unpaired as appropriate, were used (10) . In calcuilation of D50 for serum gastrin vs. acid, we expressed our results using the more simple linear model, as we did not find a better fit with logarithmic transformation of the gastrin variable. For the D50 of G17 dose-response studies, linear regression analysis was performed according to the following equation, which gave D50 as the negative slope: 
RESULTS

Gastric acid secretion
Basal and in response to peptone. The mean basal acid output and stimulated acid output after the peptone test meals was significantly greater in the duodenal ulcer patients than in the controls with all doses of peptone but not with saline alone. The mean acid output following saline alone was significantly higher (P < 0.005) than the mean basal acid output for both normal (3.5±0.5 and 2.2±0.5 mmol 30 min-', respectively) and ulcer (4.8±0.7 and 3.5±0.5 mmol 30 min-', respectively) subjects. The mean cumulative acid output of duodenal ulcer patients (61.2±4.9 mmol 180 min-1) was significantly greater (P < 0.001) than that of the controls (41.4±5.7 mmol 180 min-').
When the individual stimulated acid outputs were corrected by subtracting basal acid output, mean gastric acid responses remained significantly greater in the ulcer patients than in the controls in response to 0.5, 2.0, and 4.0% peptone meals. The mean basal-corrected cumulative acid output in response to all doses of peptone was significantly higher (P < 0.005) in the ulcer patients (37.2±2.7 mmol 180 min-') than in the controls (25.6±2.5 mmol 180 min-'). When the acid output after the saline-control meal was subtracted, to correct for the effect of gastric distention, mean stimulated acid output was significantly higher in the ulcer patients than in the controls with the 0.5, 2.0, 4.0, and 8.0% peptone test meals. Again, the mean cumulative acid output after correction for distention was significantly higher (P < 0.03) in the ulcer patients (29.0±3.0 mmol 120 min-') than in the controls (18.2±3.9 mmol 120 min-'). Acid output was also expressed as a percentage of the highest observed meal-stimulated acid output in each subject. The mean acid output was significantly higher in the ulcer patients than in the controls with 0.5, 1.0, 2.0, and 4.0% peptone test meals (Fig. 1) .
Postprandial acid secretion before and after healing ofulcer. In five patients, peptone dose-response tests were performed within 72 h of endoscopic demonstration of an active duodenal ulcer and again 4-8 wk later when the ulcer had healed at re-endoscopy. No significant differences in acid secretion were observed between the tests done when the ulcer was active and when the ulcer had healed. The cumulative acid outputs were 78.4±8. 5 G17 maximal acid output. The mean acid output after G17 infusion was significantly higher (P < 0.03) in the 23 duodenal ulcer patients (25.2±+1.6 mmol 30 min-') than in the 13 controls (18.9±2.3 mmol 30 min-').
There was a significant correlation between G17 maximal acid output and meal-stimulated maximal acid output in both the ulcer (r = 0.70, P < 0.001) and control suibjects (r = 0.66, P < 0.05). In ulcer and control subjects, meal-stimulated maximal acid output represented 65.2+6.8 and 64.6±3.4%, respectively of the G17 maximal acid output.
Serum gastrin. The mean fasting serum gastrin concentrations (femtomoles per milliliters) were similar in the duodenal ulcer patients and the controls for both G-total (27.4±1.9 and 32.7±4.4, respectively) and G17 (12.6±0.7 and 14.4±1.2, respectively). The mean levels in response to peptone test meals were also similar (Fig. 2) . The mean integrated serum gastrin levels (nanomoles per minute per liter) were similar in the ulcer patients and the controls for both G-total (6.5 ±0.5 and 6.8±0.8, respectively) and G17 (2.8±0.3 and 2.8±0.3, respectively). Likewise, the mean basal-corrected integrated serum gastrin levels were similar in the ulcer patients and controls for both G-total (2.8 ±0.4 and 2.6±0.5, respectively) and G17 (1.1±0.3 and 1.0+0.2, respectively). In both the patients and the controls, there was no significant change in the mean serum G-total or G17 level after the saline test meal when compared with basal. The lowest dose of peptone that produced a significant rise above basal of mean G-total and G17 was 2% in both patients and controls, whereas the lowest dose of peptone that produced significant increase in acid secretion over saline was 0.5% for the ulcer patients and 1% for controls. Correlation between serum gastrin concentration and meal-stimulated acid output. In each subject, the correlation coefficient between serum gastrin concentrations and gastric acid outputs in response to the graded doses of peptone was calculated and found to be positive. The median correlation coefficients both for acid output vs. G-total and for acid output vs. G17 were highly significant (P < 0.001) in both the duodenal ulcer patients and in the controls (Table I) . These correlation coefficients remained highly significant regardless of whether uncorrected values for acid output and serum gastrin concentrations were used, or whether they were corrected by subtracting values observed during the basal period or during the period in which the stomach was distended with 0.15 M NaCl (Table I) .
The relationship between mean meal-stimulated serum gastrin concentrations and mean acid output after infusion of the graded doses of peptone in the duodenal ulcer patients and the controls is depicted for G17 in Fig. 3 . The curve for the duodenal ulcer patients is distinctly to the left of that of the controls. Correlation within individuals between serum gastrin (C-total or G17) and acid output in response to graded doses of peptone meals in duodenal ulcer (DU) and normal (N) subjects. The correlation coefficient was calculated for each subject individually and the table gives the median correlation coefficient (r) with the ranges in parentheses. P < 0.001 for each median r. Both the gastrin values and the acid output values were corrected by subtracting the values observed during the basal period or during the period with distention from 0.15 M NaCI.
Among individuals of both ulcer and control groups, there was no significant correlation between peak serum concentration, whether G-total or G17, and maximal acid output in response to peptone; nor between integrated serum gastrin level, whether G-total or G17; and cumulative acid output in response to peptone.
GASTRIC ACID mmol 30min-1
Half-maximal acid response and corresponding serum gastrin concentrations. From the regression line of each subject, the serum gastrin concentration corresponding to half of the observed maximal acid output in response to the peptone tests meals was calculated. This serum gastrin concentration was designated D50M-Duodenal ulcer patients had a significantly lower D50M than the controls with respect to both G-total and G17, irrespective of whether the absolute values or the basal-corrected values were used (Table II) .
It was possible to match 13 of the control subjects with 13 duodenal ulcer patients with respect to maximal acid output in response to peptone to within 1.5 mmol 30 min-' for each pair. The D5OM of the duodenal ulcer patients remained significantly less than that of their matched controls with respect to both G-total and G17 (Table III) . The mean maximal acid output observed in the remaining 12 duodenal ulcer patients was significantly higher than that of the 14 controls. In these 12 ulcer patients, the mean D50M for both G-total and G17 was still significantly lower than that of the controls, but not significantly different from the ulcer patients whose acid secretion matched that ofthe controls.
It was also possible to match 10 of the control subjects with 10 of the duodenal ulcer patients for their G17 maximal acid output to within 2 mrihol 30 min-' for each pair. The D50M of the duodenal ulcer patients was significantly less than that of their matched controls with respect to both G-total and G17 (Table III) . The mean G17 maximal acid output of the remaining 13 ulcer patients who underwent this test was significantly higher than that of the 13 controls who had the test performed. In the latter 13 ulcer patients, the mean D50M for both G-total And G17 was still significantly lower than that of the controls, but not significantly different from the ulcer patients whose G17 maximal acid output matched that of the controls.
In both ulcer patients and controls, there was no sig- G17, and maximal acid outpuit, whether meal stimulated or G17 stimulated. G17 dose response. The mean acid output, whether uncorrected (Fig. 4) or corrected for basal effect by subtraction, was significantly higher in duodenal ulcer patients than in control subjects after each dose of G17. In each subject a linear regression line was constructed for acid output, y vs. acid output/dose, x. The median correlation coefficient for ulcer patients was -0.81 (range; -0.50--0.99) and that for nonnal controls was -0.66 (range; -0.34--0.99). From the regression line of each subject, the G17 dose corresponding to half of the maximal acid output was calculated and designated l)5o(;. Mean D50G (piComoles per kilogram per hour) was significantly lower (P < 0.0005) in duodenal ulcer patienits (42.1±3.9) than in control subjects (79.9±5.5). To ing infusion ofthe various doses ofG17 were not measured. However, previous G17 dose-response studies in which these were done indicate that increase in sertum G17 levels correlated significantly (r = 0.999) with anl exogenous G17 dose, and that the clearaince of G17 in duodenal ulcer patients was identical to that of normiial cointrols (12) .
Correlationi betwceetn G17 D5OM atnd Dst;. 1),-,\I of serum G17 concentratioins in response to peptonie test meals was correlated with D5IG of G17 (loses obtainie(d in the G17 dose-response studies. A signiificant (P < 0.01) correlation was observed in (tio(lenial uilcer patients and control subjects regardless of whether the uncorrected (Fig. 5 ) values (r = 0.65 and( r = 0.72, respectively) or the values corrected for basal effect (r = 0.70 and r = 0.72, respectively) were uise(l. DISCUSSION We have shown that by stimulating gastric aci(d secretion with increasing concentrations of peptonie, a highly significant correlation was observed within individual subjects between the meal-stimulated serumiii gastrin levels, G-total or G17, and the corresponding acid output. These data provide aditional evidence that G17 is a major physiologic mediator of the acid secretory response to intragastrically instilled proteincontaining meals. In the present series of du mean meal-stimulated serum of the normal controls, a find previous studies (14, 15) , in intragastric titration (3, 13) , b (16) . The differences amoni understood but may in part re of duodenal ulcer disease (1 methods.
In agreement with previou response to a steak meal as titration was higher than nor tients, we observed that th each concentration of peptc icantly higher in the duode the controls. The meal-stimul higher in duodenal ulcer pa subjects even when the basa stimulated secretions were postprandial acid responses scopically active duodenal u after the ulcer healed.
The 8% 500-ml peptone do mal or near maximal dose be to 10 or 16% did not increas In both ulcer and control su prandial acid output correla G17 maximal acid output. Th( gest that postprandial maxim ent on the parietal cell mass is a major determinant of ma: ulcer and control subjects, t acid output averaged about t NORMAL mal acid output. These findings agree with previous r=0.72 0 0 studies (4, 19, 20) ulcer patients than in the controls. The difference was ant correlation within in-most striking (P < 0.0005) when the circulating G17 individuals, explains the was considered. Secondly, the mean D50G, i.e., the dose '3, 4, 13) to correlate meal-of exogenous G17 required for half of the G17 maximal responses.
acid output, was significantly less in ulcer than in coniodenal ulcer patients the trol subjects, as observed both in previous (2) and presgastrin was similar to that ent studies. Furthermore, in both ulcer and control ling in keeping with some subjects, there was a significant correlation between cluding those employing the exogenous D50G and the endogenous D50,1. These ut at variance with others findings strongly suggest: that exogenous circulating g various studies are not G17 was the mediator of the peptone-stimulated acid present the heterogeneity response, further supporting previous work (5); and 17, 18) and differences in that ulcer patients require less circulating gastrin for a given acid response. ts findings (3) that the acid
The increased sensitivity to endogenous gastrin in measured by intragastric the ulcer patients was further demonstrated by matchmal in duodenal ulcer pa-ing the controls with ulcer patients having similar poste mean acid response to prandial maximal acid output. Even though their postne test meal was signif-prandial maximal acid output was similar to that of nal ulcer patients than in the controls, these ulcer patients still had a significantly lated acid output remained lower D50M than the controls. The remaining ulcer paLtients than in the control tients, whose mean postprandial maximal acid output 1-and distention (saline)-was significantly higher than that of the controls, also subtracted. Furthermore, had significantly lower D50M. Thus, these findings demin patients with endo-onstrate that duodenal ulcer patients, whether their lcer remained unchanged postprandial maximal acid secretion was within or above the normal limit, had increased acid-secretory sensitivse is likely to be the maxi-ity to postprandial gastrin. cause increasing the dose Furthermore, in ulcer patients and control subjects e the acid output further. matched for similar G17 maximal acid output, the mean ibjects, the maximal post-G-total and G17 D50M for the meal-stimulated acid reted significantly with the sponse were significantly lower in the ulcer patients. ese findings therefore stg-This was also seen in the remaining ulcer patients al acid output is depend-whose mean G17 maximal acid output was significantly i, assuming that the latter higher than that of the controls. These findings indiximal acid output. In both cate that a lower D5OM was present in the ulcer patients the postprandial maximal independent of their capacity to secrete acid. wo-thirds of the G17 maxi-
The cause of the increased sensitivity of duodenal ulcer patients to endogenous gastrin is unknown. It may be the result of vagal hyperactivity as first suggested by Dragstedt (22) . An increased cholinergic drive is supported by the pentagastrin dose-response studies of Roland (23) , which showed that carbacholine reduced the D50 of pentagastrin in the normals but not in the duodenal ulcer patients. The D50 with carbacholine in the normals was similar to that of the ulcer patients, suggesting preexisting heightened vagal cholinergic tone in duodenal ulcer subjects. Our findings thus indicate that a pathophysiologic defect occurs in the gastric phase of acid secretion in duodenal ulcer patients. This defect is present both in patients with normal and increased maximal acid response to G17. The lower D5OM in the duodenal ulcer patients also implies that small meals would lead to relatively greater acid secretion in ulcer patients than in normal subjects. Treatment with frequent small meals for duodenal ulcer patients may therefore be inappropriate.
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